Inhibition of extrinsic coagulation activation in endotoxemia; therapeutic implications
Ten Cate, H.; Levi, M.; van der Poll, T.; Biemond, B.J.; van Deventer, S.J.; Buller, H.R.; ten Cate, J.W.
Progress in Clinical and Biological Research 388: 215-219
1994
ISSN/ISBN: 0361-7742 PMID: 7831360 Document Number: 432796
Document emailed within 1 workday
Related Documents
Bom, V.J.; van Hinsbergh, V.W.; Reinalda-Poot, H.H.; Mohanlal, R.W.; Bertina, R.M. 1991: Extrinsic activation of human coagulation factors IX and X on the endothelial surface Thrombosis and Haemostasis 66(3): 283-291Doellgast, G.J.; Triscott, M.X.; Buss, D.H.; West, J. 1988: Extrinsic-pathway enzyme-linked coagulation assay (EP-ELCA). a clot-based alternative to prothrombin time for measurement of extrinsic pathway factors in plasma Clinical Chemistry 34(2): 294-299
Biemond, B.J.; Levi, M.; ten Cate, H.; Soule, H.R.; Morris, L.D.; Foster, D.L.; Bogowitz, C.A.; van der Poll, T.; Büller, H.R.; ten Cate, J.W. 1995: Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa Thrombosis and Haemostasis 73(2): 223-230
Haas, S.; Walenga, J.M.; Jeske, W.P.; Fareed, J. 1999: Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications Seminars in Thrombosis and Hemostasis 25(Suppl 1): 67-75
Fukutake, K.; Ogiso, J.; Matsubare, Y. 1979: Determination of extrinsic coagulation factors Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 2221-2231
Nakahara, Y.; Takemoto, S.; Kamikubo, Y.; Miyamoto, S. 1997: Vascular smooth muscle cell and extrinsic coagulation pathway Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 104: 205-215
Barrowcliffe, T.W.; Marshall, D.E.; Trickett, L.P.; Hubbard, A.R.; Gray, E.; Thorpe, R. 1989: Procoagulant activity of T lymphoblastoid cells in extrinsic and intrinsic coagulation systems Thrombosis and Haemostasis 62(3): 880-884
Osterud, B.; Kasper, C.K.; Lavine, K.K.; Prodanos, C.; Rapaport, S.I. 1981: Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VIi and bovine tissue factor Thrombosis and Haemostasis 45(1): 55-59
Ou, J.; Molina, L.; Kim, Y.M.; Billiar, T.R. 1996: Excessive NO production dose not account for the inhibition of hepatic gluconeogenesis in endotoxemia American Journal of Physiology 271(4 Pt 1): G621-G628
Huang, L.; Xie, J.-n.; Liang, J.-p.; Li, Y.-h.; Zhou, Y. 2011: Sophoridine inhibits NF-kappaB signaling pathway activation in kidney tissue of endotoxemia mice Yao Xue Xue Bao 46(9): 1072-1077
Fischman, C.M.; Udey, M.C.; Kurtz, M.; Wedner, H.J. 1981: Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence Journal of Immunology 127(6): 2257-2262
Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation Thrombosis and Haemostasis 77(3): 498-503
Mohler, K.M.; Torrance, D.S.; Smith, C.A.; Goodwin, R.G.; Stremler, K.E.; Fung, V.P.; Madani, H.; Widmer, M.B. 1993: Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists Journal of Immunology 151(3): 1548-1561
Komiyama, Y.; Takahashi, H. 1998: Atherosclerosis and activation of platelet and blood coagulation Rinsho Byori. Japanese Journal of Clinical Pathology 46(7): 678-683
Koyama, T. 2010: Analyses on activation and regulation of blood coagulation Rinsho Byori. Japanese Journal of Clinical Pathology 58(1): 45-57
Menguy, E.; Fremanger, P.; Alibert, F.; Mangez, J.F.; Roux, P.; Winckler, C. 1987: Activation of coagulation following surgery of intracranial meningioma Presse Medicale 16(12): 587-588
Caine, Y.G.; Bauer, K.A.; Barzegar, S.; ten Cate, H.; Sacks, F.M.; Walsh, B.W.; Schiff, I.; Rosenberg, R.D. 1992: Coagulation activation following estrogen administration to postmenopausal women Thrombosis and Haemostasis 68(4): 392-395
P.C.Bartels, M.; Schoorl, M.; A.A. van Bodegraven 2001: Reduction of Preanalytical Errors Due to in Vitro Activation of Coagulation Clinical Laboratory 47(9-10): 449-452
Guillin, M.C.; Bezeaud, A. 1985: General mechanisms of coagulation and their physiological inhibition. I. General mechanisms of blood coagulation Pathologie-Biologie 33(8): 847-857
Wartiovaara, U.; Mikkola, H.; Szôke, G.; Haramura, G.; Kárpáti, L.; Balogh, I.; Lassila, R.; Muszbek, L.; Palotie, A. 2000: Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A Thrombosis and Haemostasis 84(4): 595-600